98%
921
2 minutes
20
Chronic hypercortisolemia is a hallmark of neuroendocrine and psychiatric disorders, such as Cushing's disease and depression. Whether cortisol directly contributes to the altered mood and anxiety symptoms seen in these diseases remains unclear. To address this, the authors have modeled hypercortisolemia by administering corticosterone in the drinking water of female Swiss Webster mice for 17 or 18 days (13 mg/kg). Light-dark emergence, startle habituation, and startle reactivity were measured. Chronic but not acute treatment with corticosterone increased the latency to emerge into the light compartment, an anxiogenic-like effect. Chronic corticosterone treatment did not affect startle habituation, but did reduce startle reactivity. This study suggests that chronic hypercortisolemia may contribute to anxiety-related behavior in patients with Cushing's disease and depression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1037/0735-7044.120.2.249 | DOI Listing |
Braz J Med Biol Res
June 2025
Laboratório de Neurofisiologia da Dor e do Comportamento, Departamento de Psicologia, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil.
The incidence of chronic pain in the general population is highly correlated to anxiety disorders, which promote negative effects on the quality of life. Stretch injury is the primary cause of nerve dysfunction and injury in the civilian population. Here, we characterized changes in nociception, anxiogenic-like behaviors, and astrocyte expression in the low-intensity sciatic nerve-stretch injury (NSI) model.
View Article and Find Full Text PDFBrain Sci
February 2025
School of Medical Technology and Translational Medicine, Hunan Normal University, Changsha 410006, China.
Background: Major depressive disorder is a common mental health issue characterized by persistently low mood and high morbidity and mortality. The major pathophysiology is neuroinflammation, as evidenced by elevated cytokine levels. Patients often fail to achieve full remission with the use of currently available antidepressants, prompting the search for new treatment options.
View Article and Find Full Text PDFOxf Open Neurosci
November 2024
Department of Psychology, The University of Texas at El Paso, El Paso, TX 79968.
Anxiety-related illnesses constitute one of the leading causes of disability across the globe. Consequently, the need for validated preclinical models to uncover the etiology of anxiety phenotypes remains essential. Given the link between social stress experience and the manifestation of anxiogenic-like outcomes, we evaluated whether social defeat stress (SDS) reduces open-space exploratory behavior in prairie voles ().
View Article and Find Full Text PDFLife Sci
December 2024
PUCRS, Programa de Pós-Graduação em Odontologia, Escola de Ciências da Saúde e da Vida, Porto Alegre, RS, Brazil; PUCRS, Centro de Pesquisa em Toxicologia e Farmacologia, Escola de Ciências da Saúde e da Vida, Porto Alegre, RS, Brazil; PUCRS, Curso de Graduação em Odontologia, Escola de CiÃ
Aims: Fibromyalgia patients might experience temporomandibular disorder (TMD) as a comorbidity. However, the connection between these two syndromes is not fully understood. Nociceptin (N/OFQ) and NOP receptors are implicated in both conditions, but their relevance in the comorbidity needs investigation.
View Article and Find Full Text PDFNeurosci Lett
August 2024
Department of Pharmacology, School of Medicine, Hunan Normal University, Changsha 410013, China; Hunan Province People's Hospital, The First-Affiliated Hospital of Hunan Normal University, Changsha 410081, China. Electronic address:
Shikonin is an active naphthoquinone with antioxidative, anti-inflammatory, and anticancer properties. In this study, we investigated the effects of shikonin on depressive- and anxiety-like behaviors in lipopolysaccharide- (LPS-) induced depression and chronic unpredictable mild stress (CUMS) rat models and explored the potential mechanism. First, a 14-day intraperitoneal administration of shikonin (10Â mg/kg) significantly decreased immobility time in forced swimming test (FST) and increased open arm entries in elevated plus maze (EPM) test, without affecting line crossings in open field test (OFT), indicating that shikonin has anti-depressant- and anxiolytic-like effects.
View Article and Find Full Text PDF